Stay updated on XmAb®20717 in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision v3.5.0 was added to the record history and revision v3.4.3 was deleted.SummaryDifference0.1%

- Check8 days agoChange DetectedThe Record History shows an added revision entry for v3.4.3 and a removed entry for v3.4.2.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedAdded Revision: v3.4.2 to the study history. Removed an outdated funding notice and the older Revision: v3.4.1 from the page history.SummaryDifference0.8%

- Check44 days agoChange DetectedSite-wide notices were added about a lapse in government funding and the NIH Clinical Center status, and a new release note (Revision: v3.4.1) was added; the previous release note (Revision: v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check51 days agoChange DetectedGlossary display has been added, and the UI now explains how added and deleted items are color-coded. The 'No FEAR Act data' section was removed and the revision label was updated to v3.4.0.SummaryDifference1.0%

- Check65 days agoChange DetectedRevision history updated to include Revision: v3.3.4 and remove Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to XmAb®20717 in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page.